Long-term effects of the Eclipse cigarette substitute and the nicotine inhaler in smokers not interested in quitting

Nicotine and Tobacco Research

Volumn 4, Issue SUPPL. 2, 2002, Pages

  Fagerström, Karl Olov ^a   Hughes, John ^b   Callas, Peter W ^c  

^a Fagerstrom Consulting AB   (Sweden)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; CARBOXYHEMOGLOBIN; COTININE; HEMOGLOBIN; NICOTINE;

ADULT; ARTICLE; BLOOD LEVEL; CIGARETTE SMOKING; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; EXPIRED AIR; HEMOGLOBIN DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; NICOTINE REPLACEMENT THERAPY; OUTCOMES RESEARCH; PRIORITY JOURNAL; SMOKING CESSATION; STATISTICAL ANALYSIS; WITHDRAWAL SYNDROME;

EID: 0036961533     PISSN: 14622203     EISSN: None     Source Type: Journal    
DOI: 10.1080/1462220021000032771     Document Type: Article

References (15)

1. Benowitz, N. (1999). Treatment of nicotine dependence in clinincal cardiology. CVD Prevention, 2, 135-139.
2. Bolliger, C. T., Zellweger, J. P., Danielsson, T., Biljon, X., Robidou, A., Westin, A., Perruchoud, A. P., & Sawe, U. (2000). Smoking reduction with oral nicotine inhalers: double blind, randomized clinical trial of efficacy and safety. British Medical Journal, 321, 329-333.
3. Breland, A. B. (2001, March). Comparison of the withdrawal suppression, psychological effects, and nicotine delivery of two novel smoking systems. Paper presented at the annual meeting of the Society for Research on Nicotine and Tobacco, Seattle, WA.
4. Fagerström, K. O., Tejding, R., Westin, Å., & Lunell, E. (1997). Aiding reduction of smoking with nicotine replacement medications: Hope for the recalcitrant smoker? Tobacco Control, 6, 311-316.
5. Fagerström, K. O., Hughes, J. R., Rasmussen, T., & Callas, P. W. (2000). A randomised trial investigating the effect of a novel nicotine delivery device (Eclipse) and a nicotine oral inhaler on smoking behaviour, nicotine and carbon monoxide exposure, and motivation to quit. Tobacco Control, 9, 327-333.
6. Frampton, M. W., Hyde, R. W., Torres, A., Perillo, I., Pietropaoli, A., O'Mara, R.. Azadniv, M. Frasier, L., Speers, D. Smith, C., & Utell, M. J. (2000). Lung injury and inflammation in smokers: effects of switching to a new cigarette. European Respiratory Journal, 16, 187.
7. Lunell, E., Molander, L., Leischow, S. J., & Fagerström, K. O. (1995). Effect of nicotine vapour inhalation on the relief of tobacco withdrawal symptoms. European Journal of Clinical Pharmacology, 48, 235-240.
8. Pauly, J. L., Lee, H. J., Hurley, E. L., Cummings, M. K., Lesses, J. D., & Streck, R. J. (1998). Glass fiber contamination of cigarette filters: an additional health risk to the smoker? Cancer Epidemiology, Biomarkers & Prevention, 7, 967-979.
9. Schuh, K. J., Schuh, L. M., Henningfield, J. E., Stizer, M. L. (1997). Nicotine nasal spray and vapor inhaler: abuse liability assessment. Psychopharmacology, 130, 352-361.
10. Smith, C. J., McKarns, S. C., Davis, R. A., Livingston, S. D., Bombick, B. R., Avalos, J. T., Morgan, W. T., & Doolittle, D. J. (1996). Human urine mutagenicity study comparing cigarettes which burn or primarily heat tobacco. Mutation Research, 361, 1-9.
11. Stratton, K., Shetty, P., Wallace, R., & Bondurant, S. (Eds.). (2001). Committee to Assess the Science Base for Tobacco Harm Reduction, Institute of Medicine. Clearing the Smoke: Assessing the Science Base for Tobacco Harm Reduction. Washington, DC: National Academy Press.
12. Umino, T., Manouilova, L. S., Skold, C. M,, Pirrucello, S. J., Spurzem, J. R., & Rennard, S. I. (1999). Effect of a cigarette which does not burn tobacco on phenotypical markers of alveolar macrophages from heavy smokers. European Respiratory Journal, 14, 2988.
13. U. S. Department of Health and Human Services. The heath benefits of smoking cessation: A Report of the Surgeon General. (DHHS Publication No [CDC] 90-8416, 1990). Washington, DC: Office on Smoking and Health.
14. Wald, N. J., Howard, S., Smith, P. G., & Kjeldsen, K. (1973). Association between atherosclerotic disease and carboxyheamoglobin levels in tobacco smokers. British Medical Journal, 1, 761-765.
15. Woodson, P. P., Fagerström, K. O., Molander, L., Slade, J., Henningfield, J. E. (1993). Premier: A new nicotine delivery system-studies on its environmental and biological impact. Journal of Smoking Related Diseases, 4, 191-201.